About Amit Vohra
Form D filings for Neuro42 in 2024 list Amit Vohra as CEO and director.
Form D filings also name Amit Vohra as CEO and director at Promaxo and Promaxo.
Amit Vohra first appears on SEC filings in 2017.
Experience
This experience comes from Amit Vohra's profile and from SEC filings. For roles taken from filings, the years are when the filings name Amit Vohra in the role, so the role may have started earlier or lasted longer.
8I
8chili Inc Current
Co-Founder & Director
2019 – Present
NA
Navaux Current
Director
2019 – Present
UE
UF Herbert Wertheim College of Engineering Current
West Coast Advisory Board Member
2019 – Present
Promaxo Holdings, Inc. Current
Founder, President & CEO (2016 – Present)
Director
2016 – Present · Oakland, CA
MRI systems that help clinicians guide prostate biopsies.
TT
TriOcula Technologies Current
Executive Director and Advisor
2016 – Present
FA
Fanisko Current
Strategic Advisor and Angel Investor
2014 – Present
AC
Advanced Biopharma Consulting Current
Partner
2009 – Present
WP
Weinberg Medical Physics
Strategic Business Consultant and Advisor
2015 – 2018
CI
Convergent Life Sciences, Inc
Co-Founder, CEO, President and EVP of Operations and Business Development
2012 – 2014
NL
Navya Biomedical Technologies LLC
Co-Founder and President
2009 – 2012
EI
Eigen
VP Strategy and Operations
2008 – 2012
AL
Air Liquide
Senior Research Associate
2006 – 2008
UF
University of Florida
Graduate Research Assistant
2001 – 2005
Key Colleagues at Startups
The people Amit Vohra works with at each company, as listed on that company's latest Form D.
Promaxo Holdings, Inc. · Form D, Mar 30, 2026
Neuro42, Inc. · Form D, Sep 16, 2024
Promaxo, Inc. · Form D/A, Jul 10, 2024
Michael Bartholomew
Executive officer and director
JC
Jonathan Chen
Director
DH
Derek Hennecke
Director
DC
Dushyant Chipalkatty
Director
DK
Dinesh Kumar
Executive officer